| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |